Neonatal shortcuts

23/02/2026

👀👀👀

23/02/2026

Echocardiographic indicators of an hsPDA

30/01/2026

Despite extensive research in basic science and in clinical settings with thousands of infants over decades, uncertainty and controversy persist regarding the significance, assessment, and management of the patent ductus arteriosus (PDA) in preterm infants, resulting in substantial variability in cl...

30/01/2026

This is the first literature economic evaluation of caffeine for AOP. Despite increasing the cost of therapy, HD maintenance caffeine seems to be a cost-effective alternative to LD caffeine in Qatar. Our results support the recent global trends of increased use of HD caffeine for AOP in NICU.

29/01/2026

Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy: Clinical Report

Therapeutic hypothermia to a temperature of 33.5 to 34.5 °C initiated within 6 hours of birth and continued for 72 hours reduces the risk of death or moderate-to-severe neurodevelopmental impairments in neonates with moderate-to-severe hypoxic-ischemic encephalopathy (HIE) born at ≥36 0/7 weeks o...

17/12/2025

Norepinephrine versus Dopamine for Septic Shock in Neonates: A Randomized Controlled Trial

To assess the effect of norepinephrine (NE) vs dopamine (DA) as first-line vasoactive agent in neonates with fluid-refractory septic shock.

17/12/2025

https://pubmed.ncbi.nlm.nih.gov/40234559/

16/12/2025

16/12/2025

Abstract. Introduction: Hypoxic-ischemic encephalopathy (HIE) is a leading cause of neonatal mortality and neurodevelopmental disabilities. Therapeutic hypothermia (TH) is the standard of care, but optimized sedoanalgesic strategies remain critical. Dexmedetomidine shows promise as an alternative to...

16/12/2025

To evaluate the safety and efficacy of dexmedetomidine as the primary sedative in neonates. Single center, retrospective study of mechanically ventilated neonates sedated with dexmedetomidine (study group) or opioids/benzodiazepines (control group). Primary outcome was requirement of opioids/benzodi...

16/12/2025

Maternal and Neonatal Outcomes in Gestational Hypertension for Delivery at 37 versus 38 to 40 Weeks https://ow.ly/hpfN50XF5Oa

15/12/2025

This case series presents survival and morbidity outcomes for infants born alive and resuscitated at 21 weeks’ gestational age at a center that attempts resuscitation in selected cases.